St. Jude Medical Announces FDA Approvals of New Pacemakers

St. Jude Medical, Inc. , a global medical device company, today announced approval from the U.S. Food and Drug Administration for the Allure Quadra™ Cardiac Resynchronization Therapy Pacemaker , which provides additional pacing innovations for physicians to treat patients with heart failure.



from Content Keyword RSS http://ift.tt/1hlCaV5

via IFTTT